Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2023-03
Stage
Seed
Founded
2021
Headcount
28
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Protai is an AI-powered drug discovery startup that combines deep proteomics research with machine learning to combat complex diseases. The company has developed an end-to-end AI-based platform that comprehensively maps the course of a disease at the protein level, enhancing the ability to observe cellular function and improve drug discovery. Protai's technology analyzes proteins, their activity, and interactions to predict changes that will lead to effective disease cures and drug development. They aim to improve patient response prediction to drugs and discover novel drug targets that genomic approaches may have overlooked.
Headcount over time
28 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Q&A
- What is Protai's primary focus in drug discovery?
- Protai focuses on AI-powered drug discovery, utilizing deep proteomics research and machine learning to map diseases at the protein level and improve drug development.
- How much funding has Protai raised in total?
- Protai has raised a total of $20,000,000.
- When did Protai complete its most recent funding round and for what amount?
- Protai completed a Seed funding round in March 2023, raising $12,000,000.
- Which investors participated in Protai's Seed round in January 2022?
- Protai's Seed round in January 2022 included investments from Grove Ventures.
- What is the current employee count for Protai?
- Protai has 28 employees, falling within the 11-50 employee bucket.
- What recognition did Protai receive in May 2026?
- In May 2026, Protai was awarded as one of the Most Innovative Life Science Startups at Biomed Israel 2026.
- What is Protai's primary sector classification?
- Protai's primary sector classification is Health Tech & Life Sciences.
Team · 16
Eran Seger
Founder · CEO
Kirill Pevzner
Founder · CTO
Yaron Ben Shoshan-Galeczki
Computational Chemist
Alon Shtrikman
Software & Algorithms
Andy Morley
Medicinal Chemistry
Anjana Shenoy
Head of Proteomics
Dimitri Kovalerchik
Proteomics Scientist
Gali Arad
Head of Product
Galina Otonin
Research Associate
Iris Alchanati
Lab Manager
Katharina Lange
Systems Biologist
Michal Ran Shchory
Software & Algorithms
Nitzan Simchi
Head of Software & Algorithms
Noam Cohen
Biological Researcher
Sagie Brodsky
Systems Biology
Yonatan Kedem
Head of Drug Discovery
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
data-analyticsbiotechnologydecision-supportdisease-managementproteinsdigital-healthcareartificial-intelligencedrug-discoverypersonalizationsoftware-platformpharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | protai.bio |
|---|---|
| linkedin.com/company/74514047 |
Identifiers & details
| Legal name | Protei Bio Ltd. |
|---|---|
| Founded | 2021 |
| Employees (exact) | 28 |
Radar intelligence
Patents
| EPO | 51 |
|---|
Publications (Crossref)
| Works | 3 |
|---|
GitHub
| Top repos | co-folding-benchmark |
|---|
Web history (Wayback)
| Domain | protai.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516427895 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-07-05 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 1 — charge (1) |
| Registered address | שוהם 5 רמת גן |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-06 | סילוק שעבוד |